ArticleResearch square2025

Sequencing analysis reveals evidence of immune activation in advanced HER2 negative breast cancer responders treated with entinostat + nivolumab + ipilimumab.

Evanthia Roussos Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.